All entries for: Apogee Therapeutics

March 2, 2026

Apogee Therapeutics

Neutral Outlook

Waltham, MA
201-500 employees

For example, the IRA, among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in ACA marketplaces through plan year 2025. The IRA also eliminates the “donut hole” under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program.

Disease Area: Gastrointestinal, Immune Diseases, Respiratory Diseases
Drug Type: Biologic
Scroll to Top